person · Reporting owner
HUTCHINSON DEBORAH JENKINS
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sanara MedTech Inc.WNDM · Entity 5880 | President | October 24, 2016 | March 31, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sanara MedTech Inc.
Report date October 24, 2016 · Filed March 31, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,750,000 |
Reported balance
After 2016-10-24 transaction · row 1
1 source rowRow 1 · 2016-10-24 · Grant · Acquired 500,000 · Balance 2,750,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 24, 2016 Filed Mar 31, 2017 18:52 UTC | Sanara MedTech Inc. WNDM · Entity 5880 | GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001492839-17-000001 · primary_doc.xml · nonDerivative · entry 1 HUTCHINSON DEBORAH JENKINS · CIK 0001492839 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.